This wiki has undergone a migration to Confluence found Here
20130522 BAM Modeling
Jump to navigation
Jump to search
TSC representatives and ArB to jointly develop content for the BAM for the Product Line Architecture Program
HL7 BAM Modeling Call Minutes Location: call 770-657-9270 using code 985371# |
Date: 2013-05-22 Time: 2 pm Eastern Time | ||
Facilitator | Ron Parker | Note taker(s) | Lynn |
Attendee | Name
| ||
Calvin Beebe | |||
Woody Beeler | |||
Jane Curry | |||
Bo Dagnall | |||
Jean Duteau, | |||
Tony Julian | |||
Austin Kreisler, | |||
Lynn Laakso | |||
Cecil Lynch | |||
Ravi Natarajan | |||
Ron Parker | |||
Brian Pech | |||
Melva Peters | |||
Quorum Requirements Met: (yes/No) | |||
quorum definition? |
Agenda
Agenda
- Review minutes of 20130508_HL7_PLA_Meeting
- update of ArB a-ha moment on three axes of product platform as a paradigm (technology binding/context); product line as a business domain (Function), and product family as a methodology (Form)
- Discuss Security Risk Assessment Cookbook process
- update on simplified data collection spreadsheet Ron/Jane
- Next steps for engagement with the cochairs - Result of TSC discussion on updates to WGM agenda template/icons and cochair education session
Reference Documents
- BAM Overview BAM status as of Jan WGM
- Fill in spreadsheet
Minutes
Agenda - need to refine messages to Structured Documents and confirm understanding out of WGM; 3-axis paradigm needs refinement before discussion on BAM. Recursion complexity of product family within product family discussed.
- asking them to surface this in their agenda setting to identify separation of concerns as a means of addressing governance vs management vs methodology.
- If you don't you simply follow the path of least resistance in conflict, even internal conflict.
- Need a narrative describing outline for their calls such as what we're doing in TSC. Here's the things you think about as you separate out your agenda discussion. Updated governance 101 deck in separating out governance, methodology and management (GMM). One-pager on how to run a call using GMM and what does it mean to how the WG behaves with respect to a project.
- SDWG Calls are about projects, management of issues coming forward, etc.
- Austin set up a recurring monthly call with the SDWG cochairs first Tuesdays at 11 where they can talk about this. Ron needs to join the call.
- Need an outline of tasks at hand.
- Chopped down version of Governance 101 along with concrete suggestions on what to do with their agenda especially separating out governance and management and teasing out methodology as well.
- Need BAM checklist for initiation of PSS for CDA IG Product Family and identify deliverables of the project WRT goals/objectives/risks.
- Most SDWG calls are management focused and project oriented. Pressure now is to shoehorn as much as possible into CCDA to gain traction in meaningful use. CDA Product Line/Family is needed for governance of templating when developing R3.
- CCDA is getting too big to edit and may need to be broken into chapters as V2 is. It is over 600 pages now. Breaking it into two volumes is a management issue.
- No project scope statement for the CDA IG product line. By developing a PSS they would declare the interested parties, who are the customers, etc. This was not done for FHIR. The IG PSS would do a high-level market segmentation and statement of what they value, what constitutes success. All of these would be deliverables of the project. Risks of doing or not doing the effort should be elucidated.
- Set baseline of GMM, goals, objectives, declared risks with approach. Then you can measure when management is happening around the project then what risks need to be mitigated and how does that change our behavior. These become deliverables of the project.
- PSS already has some elements but more towards management. PSS could include checkbox for new product family or new product line and ask for notional definition of what that product family/line would be.
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2013 Health Level Seven® International. All rights reserved.